ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia

This study is ongoing, but not recruiting participants.
Study NCT00398710.   Last updated on April 4, 2008.   Information provided by AOI Pharma, Inc.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00398710


Locations
United States, Massachusetts
Dana-Farber Cancer Institute    
      Boston, Massachusetts, United States, 02115

Sponsors and Collaborators
AOI Pharma, Inc.
Dana-Farber Cancer Institute

Investigators
Study Chair:     Irene M Ghobrial, MD     Dana-Farber Cancer Institute    


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers